Vital Chemtech Ltd
Chemicals & Petrochemicals | Small Cap
Vital Chemtech Ltd, operating in the Chemical & Petrochemicals sector, showcases a mixed financial performance. The company demonstrates excellent solvency and strong liquidity, indicating a solid financial foundation. Profitability metrics also reveal impressive gross profit margins and returns on capital, equity, and assets. However, efficiency ratios are weak, suggesting challenges in asset utilization and working capital management. Growth ratios present a mixed picture, with strong revenue and asset growth offset by declines in operating profit, EPS, and net income. Coverage ratios are also concerning due to a low equity dividend coverage ratio. Overall, Vital Chemtech exhibits strong financial health in terms of solvency, liquidity, and profitability, but needs to address its efficiency and growth-related challenges to ensure sustainable performance.
Latest Report
View AllThe Latest Reports Are Not Available at the Moment. We’ll Notify You Once They’re Available.
Latest News
View AllThe Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.
- Valuation MetricsNeutral
- Market Metrics
- Stock Reports
- Stock News
- Growth Ratio4.80
- Financial Ratio4.00
- Profitability Ratio9.60
- Efficiency Ratio4.00
- Coverage Ratio5.60
- Solvency Ratio10.00
- Liquidity Ratio7.98
- Peer Assessment
- Management AssessmentBalanced
- Risk AssessmentBalanced
- 1 HourNeutral
- 2 HoursNeutral
- 4 HoursNeutral
- 1 DayNeutral
- 1 WeekNeutral
- 1 MonthNeutral
Vital Chemtech Ltd, operating in the Chemical & Petrochemicals sector, showcases a mixed financial performance. The company demonstrates excellent solvency and strong liquidity, indicating a solid financial foundation. Profitability metrics also reveal impressive gross profit margins and returns on capital, equity, and assets. However, efficiency ratios are weak, suggesting challenges in asset utilization and working capital management. Growth ratios present a mixed picture, with strong revenue and asset growth offset by declines in operating profit, EPS, and net income. Coverage ratios are also concerning due to a low equity dividend coverage ratio. Overall, Vital Chemtech exhibits strong financial health in terms of solvency, liquidity, and profitability, but needs to address its efficiency and growth-related challenges to ensure sustainable performance.
Overall Valuation Score
P/E RATIO (TTM)
22.46
Industry Median
22.59
Small Cap Median
21.70
P/E RATIO
25.50
P/B RATIO
1.11
Industry Median
1.76
Small Cap Median
1.77
P/S RATIO
0.78
Industry Median
0.89
Small Cap Median
0.88
Others
PEG RATIO
0.00
EV/EBITDA RATIO
8.00
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹43.35 as on Jun 15, 2026.
Unlock Live Chart
Please login to view interactive real-time technical charts powered by TradingView.
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
0.00
Today's Low
0.00
Today's High
The company's growth ratios present a mixed picture, with strong revenue and asset growth offset by declines in operating profit, EPS, and net income. This suggests that while the company is expanding its operations, it is struggling to translate this growth into improved profitability. The weighted average calculation method considers recent years more heavily, reflecting the current growth situation. This area needs attention to ensure sustainable growth and improved financial performance.
| Growth Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue Growth Rate | 101.72 | -16.24 | 36.73 | -5.97 | |
| Operating Profit Growth Rate | 25 | -100 | -9.09 | ||
| Earnings Per Share (EPS) Growth | -71.4 | -116.07 | -414.81 | -74.71 | |
| Asset Growth Rate | 70.37 | -0.72 | 32.85 | 20.33 | |
| Net Income Growth Rate | 0 | -112.5 | -500 | -75 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
The company's financial ratios are generally weak, with low adjusted EPS, cash EPS, and book value per share. While capital expenditures are well-managed, the overall financial performance is concerning. The weighted average calculation method considers recent years more heavily, reflecting the current financial situation. This area needs attention to improve the company's overall financial health.
| Financial Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Adjusted Earnings Per Share (Adjusted EPS) | 11.43 | 3.33 | 0 | 1.67 | 0.42 |
| Cash Earnings Per Share (Cash EPS) | 12.86 | 4.17 | 0.83 | 3.75 | 2.92 |
| Book Value Per Share | 21.43 | 37.5 | 35 | 38.33 | 41.25 |
| Dividend Per Share (DPS) | 0 | 0.5 | 0.5 | 0 | 0 |
| Capital Expenditures (CapEx) | 8.7 | 9.5 | 20.8 | 45.8 |
Adjusted Earnings Per Share (Adjusted EPS)
Cash Earnings Per Share (Cash EPS)
Book Value Per Share
Dividend Per Share (DPS)
Capital Expenditures (CapEx)
The company's profitability ratios are strong, indicating a good ability to generate profits from its operations. High gross profit margins, return on capital employed (ROCE), return on equity (ROE), return on assets (ROA), operating margin, and net margin suggest that the company is effectively managing its costs and generating revenue. The weighted average calculation method considers recent years more heavily, reflecting the current profitability situation. This is a positive sign for the company's long-term financial health.
| Profitability Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Gross Profit Margin | 18.97 | 11.11 | -3.06 | 4.48 | 3.17 |
| Return on Capital Employed (ROCE) | 30.18 | 15 | 0 | 7 | 3 |
| Return on Equity (ROE) | 53.33 | 8.89 | -1.19 | 4.35 | 1.01 |
| Return on Assets (ROA) | 14.81 | 10.87 | 0 | 6.04 | 4.57 |
| Operating Margin | 20.69 | 12.82 | 0 | 8.21 | 7.94 |
| Net Margin | 13.79 | 6.84 | -1.02 | 2.99 | 0.79 |
Gross Profit Margin
Return on Capital Employed (ROCE)
Return on Equity (ROE)
Return on Assets (ROA)
Operating Margin
Net Margin
The company's efficiency ratios are generally weak, indicating challenges in asset utilization and working capital management. While the inventory turnover ratio and days sales in inventory are reasonable, the fixed asset turnover ratio, receivables turnover ratio, receivable days, and capital turnover ratio are all low. This suggests that the company is not efficiently using its assets to generate revenue. The weighted average calculation method considers recent years more heavily, reflecting the current efficiency situation. This area needs attention to improve the company's overall financial performance.
| Efficiency Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Fixed Asset Turnover Ratio | 3.41 | 4.68 | 2.28 | 1.97 | 2.17 |
| Inventory Turnover Ratio | 5.19 | 9.24 | 7.73 | 9.74 | 5.37 |
| Receivables Turnover Ratio | 1.38 | 2.93 | 2.53 | 3.11 | 2.9 |
| Days Sales in Inventory Ratio | 70.33 | 39.5 | 47.22 | 37.47 | 67.97 |
| Receivable Days | 264 | 124.57 | 144.27 | 117.36 | 125.86 |
| Capital Turnover Ratio | 1.59 | 1.04 | 0.98 | 1.01 | 0.89 |
Fixed Asset Turnover Ratio
Inventory Turnover Ratio
Receivables Turnover Ratio
Days Sales in Inventory Ratio
Receivable Days
Capital Turnover Ratio
The company's coverage ratios are mixed, with a reasonable interest coverage ratio but a low equity dividend coverage ratio. This suggests that the company is capable of meeting its interest obligations, but may be struggling to provide adequate returns to its equity holders. The weighted average calculation method considers recent years more heavily, reflecting the current coverage situation. This area needs some attention to ensure the company's long-term financial stability.
| Coverage Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Interest Coverage Ratio | N/A | 12 | 1 | 4 | 1.67 |
| Equity Dividend Coverage Ratio | 6.67 |
Interest Coverage Ratio
Equity Dividend Coverage Ratio
The company's solvency position is excellent, indicating a strong ability to meet its long-term obligations. Low debt ratios and a high equity ratio suggest a conservative capital structure and a reliance on equity financing. This reduces the company's financial risk and provides a solid foundation for future growth. The weighted average calculation method considers recent years more heavily, reflecting the current solvency situation. Overall, the company's solvency is a significant strength, ensuring its long-term financial stability.
| Solvency Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Debt Ratio | 0.59 | 0.2 | 0.16 | 0.3 | 0.3 |
| Debt to Equity Ratio | 1.44 | 0.25 | 0.19 | 0.43 | 0.43 |
| Equity Ratio | 0.41 | 0.8 | 0.84 | 0.7 | 0.7 |
| Debt To Asset Ratio | 0.26 | 0.16 | 0.12 | 0.22 | 0.2 |
Debt Ratio
Debt to Equity Ratio
Equity Ratio
Debt To Asset Ratio
The company's liquidity position is generally favorable, indicating a strong ability to meet its short-term obligations. High current and quick ratios suggest ample liquid assets. However, the operating cash flow ratio is poor, which may indicate difficulties in generating cash from its core operations. The weighted average calculation method considers recent years more heavily, reflecting the current liquidity situation. Despite some weaknesses, the company's liquidity is reasonable.
| Liquidity Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Current Ratio | 1.36 | 3.84 | 1.64 | 1.6 | 1.37 |
| Quick Ratio | 1.16 | 3.31 | 1.3 | 1.32 | 0.95 |
| Cash Ratio | 0.14 | 1.2 | 0.01 | 0.02 | 0.01 |
| Operating Cash Flow Ratio | -0.29 | -0.31 | 0.38 | 0.12 | 0 |
Current Ratio
Quick Ratio
Cash Ratio
Operating Cash Flow Ratio
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | Arvee Laboratories (India) Ltd | 7.86 | 72.60 | Highly Overvalued | 3.19 | 2.29 | 2.53 |
| 2 | Indian Emulsifiers Ltd | 7.24 | 5.25 | Neutral | 26.00 | 8.84 | 16.00 |
| 3 | Vital Chemtech Ltd | 7.20 | 25.50 | Neutral | 10.00 | 3.74 | 1.00 |
| 4 | Ambani Orgochem Ltd | 5.39 | 76.32 | Neutral | 16.00 | 1.77 | 1.00 |
| 5 | Hindcon Chemicals Ltd | 5.31 | 31.20 | Overvalued | 3.66 | 0.63 | 3.08 |
| 6 | Alkali Metals Ltd | 5.12 | -17.05 | Neutral | 7.72 | 0.55 | 0.56 |
| 7 | Seya Industries Ltd | 5.07 | -12.48 | Neutral | -2.74 | -1.08 | -2.87 |
The management of Vital Chemtech demonstrates potential alongside areas needing improvement. Strong sales growth and consistent promoter holding reflect positively on strategic direction and confidence. However, declining profitability margins and fluctuating borrowings raise concerns about financial management. While working capital is efficiently managed, a more consistent approach to profitability and capital allocation is necessary for sustained growth.
| Category | Metric | Value | Assessment |
|---|---|---|---|
| PROS | Sales Growth (TTM) | 36% | Demonstrates strong revenue expansion |
| Promoter Holding | 73.43% | Indicates sustained management confidence | |
| CONS | OPM Decline (Mar 2022 to Mar 2025) | 20% to 8% | Highlights challenges in maintaining profitability |
| Increase in Borrowings (Mar 2024 to Mar 2025) | 26 Cr to 48 Cr | Suggests increasing financial leverage |
Financial Performance & Growth
Vital Chemtech exhibits mixed financial performance. Sales growth is robust, with TTM growth at 36%. However, the OPM has declined, from 20% in Mar 2022 to 8% in Mar 2025. Quarterly OPM also shows volatility, ranging from -3% to 20%. Net profit turned negative in Mar 2024 before recovering to 4 Cr in Mar 2025. The company is facing challenges in sustaining profitability despite sales growth.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| Sales Growth (%) | 102.64% | -15.82% | 36.26% | |
| OPM (%) | 20% | 13% | 0% | 8% |
Capital Efficiency & Returns
Capital efficiency and returns for Vital Chemtech are weak. ROCE has declined from 15% in Mar 2023 to 7% in Mar 2025. ROE has also been relatively low, averaging around 5% over the past three years. These figures indicate that the company is not effectively utilizing its capital to generate returns.
| Metric | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|
| ROCE (%) | 15% | 0% | 7% |
| ROE (%) | 5% |
Financial Health & Prudence
Vital Chemtech's financial health presents a mixed picture. Borrowings have fluctuated, decreasing from 36 Cr in Mar 2022 to 26 Cr in Mar 2024, then increasing to 48 Cr in Mar 2025. This increase in borrowings, without a corresponding rise in profitability, could strain the company's finances. The company did not pay dividends in Mar 2022 and Mar 2025, indicating variability in profit distribution.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| Borrowings (Cr) | 36 | 29 | 26 | 48 |
| Dividend Payout (%) | 0% | 15% | -92% | 0% |
Shareholding & Ownership Structure
The shareholding pattern of Vital Chemtech indicates strong promoter confidence with a consistently high holding. Promoter holding has remained stable at 73.43% from Mar 2023 to Mar 2025. However, FII and DII holdings have decreased over the same period, with FII dropping from 3.62% in Mar 2023 to 1.78% in Mar 2025, and DII decreasing from 1.81% to 0.25%.
| Metric | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|
| Promoter Holding (%) | 73.43% | 73.43% | 73.43% |
| FII Holding (%) | 3.62% | 0.56% | 1.78% |
| DII Holding (%) | 1.81% | 0.33% | 0.25% |
Vital Chemtech faces moderate risk due to fluctuating segment performance and rising interest expenses. While the company demonstrates effective working capital management, inconsistent operational performance and increased financial leverage raise concerns. Continuous monitoring is necessary to ensure financial stability and sustainable growth.
Segment performance volatility
The company's OPM % shows volatility in quarterly results. OPM % has ranged from -3% to 20%, indicating inconsistent operational performance across different quarters. Sales figures also exhibit some fluctuation, which may affect overall profitability and stability. This suggests potential variability in segment performance, affecting overall profitability.
| Metric | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 |
|---|---|---|---|---|
| OPM (%) | 4% | -3% | 7% | 9% |
Foreign exchange or interest rate exposure
The company's interest expenses have risen over the past few years. Interest expenses increased from 0 Cr in Mar 2022 to 2 Cr in Mar 2025. This may indicate an increased exposure to interest rate fluctuations, which could impact profitability.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| Interest (Cr) | 0 | 1 | 1 | 2 |
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 1 Technical Indicators From The 1 Hour Timeframe
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 1 Technical Indicators From The 2 Hours Timeframe
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 1 Technical Indicators From The 4 Hours Timeframe
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 1 Technical Indicators From The 1 Day Timeframe
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 1 Technical Indicators From The 1 Week Timeframe
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 1 Technical Indicators From The 1 Month Timeframe